REQUEST A DEMO
Total
USD $0.00
Search more companies

Cannabian Pharma S.A.S (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Cannabian Pharma S.A.S Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Cannabian Pharma S.A.S is based in Colombia, with the head office in Bogota D.C.. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on August 31, 2018. It currently has a total number of 13 (2024) employees. The latest financial highlights indicate a net sales revenue increase of 756.48% in 2023. Its’ total assets recorded a growth of 25.86%. The net profit margin of Cannabian Pharma S.A.S increased by 380.36% in 2023.

Headquarters
Calle 142 No 12B 51 Apto 908
Bogota D.C.; Bogota D.C; Postal Code: 1005

Contact Details: Purchase the Cannabian Pharma S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Cannabian Pharma S.A.S report to view the information.
Outstanding Shares:
Purchase the Cannabian Pharma S.A.S report to view the information.
Incorporation Date:
August 31, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Cannabian Pharma S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
756.48%
Total operating revenue
756.48%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
42.55%
Total assets
25.86%
Total equity
-36.48%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
380.36%
Return on Equity (ROE)
-36.81%
Quick Ratio
-0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?